Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Syrian hamster tumor model to study oncolytic Ad5-based vectorsDebanjan Dhar, Karoly Toth, William S M WoldExpert Opinion on Biological Therapy|February 6, 2010
Oncolytic (replication-competent) adenoviruses as anticancer agentsKaroly Toth, Debanjan Dhar, William S M WoldMolecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.Journal of Virology|December 17, 2008
Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamstersDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.Current Gene Therapy|November 28, 2013
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyWilliam S M Wold, Karoly TothViruses|October 14, 2011
Increasing the efficacy of oncolytic adenovirus vectorsKaroly Toth, William S M WoldAdvances in Cancer Research|October 2, 2012
Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compoundsWilliam S M Wold, Karoly TothExpert Opinion on Pharmacotherapy|September 3, 2015
New drug on the horizon for treating adenovirusWilliam S M Wold, Karoly TothProceedings of the National Academy of Sciences of the United States of America|May 21, 2008
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal modelKaroly Toth, Jacqueline F Spencer, Debanjan Dhar, et al.Cancer Research|February 3, 2006
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectorsMaria A Thomas, Jacqueline F Spencer, Marie C La Regina, et al.Pageof 14